Data / Drug companies / Fludrocortisone acetate
Fludrocortisone acetate: 15 companies and 16 products in the FDA NDC directory
Fludrocortisone acetate is listed in the FDA National Drug Code Directory by 15 companies, with 16 products in commercial distribution. 16 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on June 2, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 16
- Generic (ANDA) products
- 16 (100.0%)
- Application numbers
- 4
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list fludrocortisone acetate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | February 25, 2025 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | September 5, 2008 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet | Generic drugs (ANDA) | March 18, 2002 |
| Amneal Pharmaceuticals of New York LLC | 1 | tablet | Generic drugs (ANDA) | March 18, 2002 |
| Ani Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | June 2, 2022 |
| AvKARE | 1 | tablet | Generic drugs (ANDA) | January 13, 2021 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | August 1, 2011 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | June 2, 2022 |
| Eywa Pharma Inc | 1 | tablet | Generic drugs (ANDA) | June 2, 2025 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | October 16, 2024 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 4, 2024 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | March 18, 2002 |
| NorthStar RxLLC | 1 | tablet | Generic drugs (ANDA) | September 7, 2023 |
| Viona Pharmaceuticals Inc | 1 | tablet | Generic drugs (ANDA) | December 2, 2024 |
| Zydus Lifesciences Limited | 1 | tablet | Generic drugs (ANDA) | December 2, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 16 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 16 | 100% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.